Tharimmune, Inc. financial data

Symbol
THAR on Nasdaq
Location
Bridgewater, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 182 % -59.4%
Debt-to-equity 123 % +3.3%
Return On Equity -588 % -2.5%
Return On Assets -264 % -1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35,044,812 shares +22.6%
Common Stock, Shares, Outstanding 7,207,341 shares +4.6%
Entity Public Float 1,700,000 USD -56.4%
Common Stock, Value, Issued 721 USD +4.6%
Weighted Average Number of Shares Outstanding, Basic 6,241,909 shares +3%
Weighted Average Number of Shares Outstanding, Diluted 6,241,909 shares +3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3,503,536 USD -33.9%
General and Administrative Expense 6,835,335 USD +17.5%
Operating Income (Loss) -10,338,871 USD +7%
Nonoperating Income (Expense) 19,626 USD -92.6%
Net Income (Loss) Attributable to Parent -10,319,245 USD +4.9%
Earnings Per Share, Basic -3 USD/shares +76.9%
Earnings Per Share, Diluted -3 USD/shares +76.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7,610,340 USD +59.4%
Assets, Current 7,699,378 USD +46.6%
Assets 7,699,378 USD +46.6%
Accounts Payable, Current 659,254 USD -15.9%
Accrued Liabilities, Current 689,804 USD -49.6%
Liabilities, Current 1,544,551 USD -30.9%
Liabilities 1,544,551 USD -30.9%
Retained Earnings (Accumulated Deficit) -43,399,789 USD -31.2%
Stockholders' Equity Attributable to Parent 6,154,827 USD +1%
Liabilities and Equity 7,699,378 USD +46.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2,689,001 USD +4.8%
Net Cash Provided by (Used in) Financing Activities 205,568 USD -35.2%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 7,207,587 shares +4.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2,483,433 USD +0.98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7,610,340 USD +59.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8,471 USD +80.2%
Deferred Tax Assets, Valuation Allowance 10,189,000 USD +52.6%
Deferred Tax Assets, Gross 10,189,000 USD +52.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital 49,623,860 USD +37.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1,524,933 USD +1.3%
Interest Expense 15,067 USD -23.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%